diltiazem has been researched along with ta 993 in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (60.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doi, H; Kaburaki, M; Murata, S; Narita, H; Yasoshima, A | 1 |
Katoh, M; Kikkawa, K; Odawara, A; Sasaki, Y; Shimazaki, T; Toryu, H | 1 |
Doi, H; Kaburaki, M; Karasawa, T; Murata, S; Narita, H; Yabana, H | 1 |
Doi, H; Inoue, H; Kaburaki, M; Narita, H; Yasuhara, M | 1 |
Doi, H; Kaburaki, M; Murata, S; Narita, H; Odawara, A; Yasoshima, A | 1 |
Doi, H; Kaburaki, M; Murata, S; Nagata, K; Narita, H; Yabana, H | 1 |
Doi, H; Ikeo, T; Karasawa, T; Katoh, M; Narita, H; Odawara, A; Takagi, M | 1 |
Doi, H; Inoue, H; Kaburaki, M; Narita, H; Suzumura, K | 1 |
Ikeo, T; Karasawa, T; Katoh, M; Odawara, A; Takagi, M; Watanabe, A | 1 |
Doi, H; Karasawa, T; Katoh, M; Odawara, A | 1 |
10 other study(ies) available for diltiazem and ta 993
Article | Year |
---|---|
Antithrombotic effect of TA-993, a novel 1,5-benzothiazepine derivative, in conscious rats.
Topics: Administration, Oral; Animals; Antithrombins; Aspirin; Diltiazem; Dose-Response Relationship, Drug; Embolism; Male; Microscopy, Electron; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombosis; Ticlopidine; Time Factors | 1995 |
Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative, on platelet aggregation.
Topics: Animals; Aspirin; Basilar Artery; Calcium; Diltiazem; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Fibrinolytic Agents; Humans; Male; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Ticlopidine; Vasoconstriction | 1996 |
Cardiovascular effect of a new 1,5-benzothiazepine derivative TA-993 in anesthetized dogs.
Topics: Animals; Brachial Artery; Cardiovascular Agents; Carotid Arteries; Diltiazem; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Female; Femoral Artery; Ganglionic Blockers; Hemodynamics; Hexamethonium; Injections, Intravenous; Male; Regional Blood Flow; Time Factors; Vasodilation | 1998 |
Cardiovascular effects of 1,5-benzothiazepine derivatives having a l-cis and d-cis configuration in anesthetized dogs.
Topics: Anesthesia; Animals; Arteries; Calcium Channel Blockers; Diltiazem; Dogs; Female; Hemodynamics; In Vitro Techniques; Male; Molecular Conformation; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Regional Blood Flow | 1998 |
Antithrombotic action of TA-993, a new 1,5-benzothiazepine derivative, in a canine model of femoral arterial thrombosis.
Topics: Animals; Antithrombins; Diltiazem; Disease Models, Animal; Dogs; Duodenum; Electric Stimulation; Female; Femoral Artery; Male; Microscopy, Electron, Scanning; Platelet Aggregation Inhibitors; Regional Blood Flow; Thrombosis | 1998 |
The mechanism of the increasing action of TA-993, a new 1,5- benzothiazepine derivative, on limb blood flow in anesthetized dogs: selective suppression of sympathetic nerve activity.
Topics: Animals; Diltiazem; Hindlimb; Perfusion; Platelet Aggregation Inhibitors; Regional Blood Flow; Sympathetic Nervous System | 1999 |
Antiplatelet mechanisms of TA-993 and its metabolite MB3 in ADP-induced platelet aggregation.
Topics: Actins; Adenosine Diphosphate; Blood Platelets; Calcium; Cyclic AMP; Cyclic GMP; Diltiazem; Dose-Response Relationship, Drug; Fibrinogen; Fura-2; Humans; Male; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding | 2000 |
Protective effect of TA-993, a novel therapeutic agent for peripheral circulatory insufficiency, on skeletal muscle fatigue in a rat model of hindlimb ischemia.
Topics: Animals; Blood Pressure; Blood Viscosity; Diltiazem; Heart Rate; Hindlimb; Ischemia; Muscle Fatigue; Pentoxifylline; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 2000 |
Inhibitory effects of TA-993 and its metabolite MB3 on platelet activation induced by collagen and U-46619 in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Triphosphate; Calcium; Collagen; Diltiazem; Humans; Male; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2 | 2001 |
Effects of the antiplatelet agent TA-993 and its metabolite MB3 on the hemorheological properties of rat and human erythrocytes.
Topics: Animals; Aspirin; Blood Viscosity; Diltiazem; Dose-Response Relationship, Drug; Erythrocytes; Hemolysis; Hemorheology; Humans; Phospholipids; Platelet Aggregation Inhibitors; Rats; Ticlopidine | 2001 |